These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 421864)
21. Clinical and laboratory examinations with Prodectin. Bédi J; Kosztovics A; Pálos LA Ther Hung; 1976; 24(3):91-7. PubMed ID: 1013926 [No Abstract] [Full Text] [Related]
22. [Treatment of atherosclerosis by pyridinolcarbamate. Review of the history of the introduction of pyridinolcarbamate and its clinical results]. Shimamoto T Rev Atheroscler (Paris); 1968; 10(3):67-84. PubMed ID: 5746502 [No Abstract] [Full Text] [Related]
23. Sequential study of biochemical changes during regression of swine aortic atherosclerotic lesions. Fritz KE; Augustyn JM; Jarmolych J; Daoud AS Arch Pathol Lab Med; 1981 May; 105(5):240-6. PubMed ID: 6894366 [TBL] [Abstract][Full Text] [Related]
24. Attempts to delay progression in occlusive atherosclerosis. Terry EN; Rouen LR; Clasuss RH; Katz MC; Redisch W Ann N Y Acad Sci; 1976; 275():379-85. PubMed ID: 1070279 [No Abstract] [Full Text] [Related]
25. [Protective effect of carbamate pyridinol on experimental atheroma in the rat]. Bouissou H; Julian M; Pieraggi MT Pathol Biol (Paris); 1974 Oct; 22(8):713-20. PubMed ID: 4614172 [No Abstract] [Full Text] [Related]
26. Comparative studies on the preventive effect of pyridinolcarbamate and estrogen against aortic and coronary atherosclerosis of cholesterol-fed rabbits. I. Topographic and pathological studies. Numano F; Katsu K; Takenobu M; Sagara A; Shimamoto T Acta Pathol Jpn; 1971 May; 21(2):177-92. PubMed ID: 5109881 [No Abstract] [Full Text] [Related]
27. The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on necrosis of atherosclerotic lesions. Daoud AS; Frank AS; Jarmolych J; Fritz KE Atherosclerosis; 1987 Sep; 67(1):41-8. PubMed ID: 3118892 [TBL] [Abstract][Full Text] [Related]
28. Ultrastructural features of aortic cells in mitosis in control and cholesterol-fed swine. Imai H; Lee KJ; Lee SK; Lee KT; O'Neal RM; Thomas WA Lab Invest; 1970 Oct; 23(4):401-15. PubMed ID: 5527807 [No Abstract] [Full Text] [Related]
29. [The angioprotector and hypolipemic activity of leukomizin in experimental atherosclerosis]. Kirmukov AG; Aĭzikov MI; Rasulova SA; Sidiakin GP; Sham'ianov ID; Malikov VM Farmakol Toksikol; 1991; 54(3):35-7. PubMed ID: 1915817 [TBL] [Abstract][Full Text] [Related]
30. Effect of a taurine treatment on the regression of existing atherosclerotic lesions in rabbits fed on a high-cholesterol diet. Balkan J; Oztezcan S; Hatipoglu A; Cevikbas U; Aykac-Toker G; Uysal M Biosci Biotechnol Biochem; 2004 May; 68(5):1035-9. PubMed ID: 15170106 [TBL] [Abstract][Full Text] [Related]
31. Enzyme histochemical observations on the effect of pyridinol carbamate on cholesterol-induced atherosclerosis. Möttönen M; Pantio M; Nieminen L Atherosclerosis; 1972; 15(1):77-82. PubMed ID: 4259028 [No Abstract] [Full Text] [Related]
32. [The comparative characteristics of the antiatherogenic effect of xymedon and parmidine]. Kamburg RA; Ibragimov OB; Kondrat'eva MB; Valeeva IKh; Shamsutdinov NSh Biull Eksp Biol Med; 1993 Aug; 116(8):205-8. PubMed ID: 8274706 [TBL] [Abstract][Full Text] [Related]
34. Sequential morphologic studies of regression of advanced atherosclerosis. Daoud AS; Jarmolych J; Augustyn JM; Fritz KE Arch Pathol Lab Med; 1981 May; 105(5):233-9. PubMed ID: 6894365 [TBL] [Abstract][Full Text] [Related]
35. Effects of regression of atherosclerotic lesions on the content and esterification of cholesterol by cell-free preparations of pigeon aorta. St Clair RW; Clarkson TB; Lofland HB Circ Res; 1972 Nov; 31(5):664-71. PubMed ID: 5084881 [No Abstract] [Full Text] [Related]
36. Cell population kinetics in atherogenesis. Cell births and losses in intimal cell mass-derived lesions in the abdominal aorta of swine. Thomas WA; Lee KT; Kim DN Ann N Y Acad Sci; 1985; 454():305-15. PubMed ID: 3865613 [TBL] [Abstract][Full Text] [Related]
37. Experimental investigation of hypolipidemic and anti-atherosclerotic drugs with different mechanism of action. Klimov AN; Ryzhenkov VE; Petrova LA; Polyakova ED Adv Exp Med Biol; 1977; 82():477-82. PubMed ID: 920403 [No Abstract] [Full Text] [Related]
38. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis]. Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681 [No Abstract] [Full Text] [Related]
39. Studies on the progression and regression of coronary and peripheral atherosclerosis in the cynomolgus monkey. I. Effects of dipyridamole and aspirin. Hollander W; Kirkpatrick B; Paddock J; Colombo M; Nagraj S; Prusty S Exp Mol Pathol; 1979 Feb; 30(1):55-73. PubMed ID: 217724 [No Abstract] [Full Text] [Related]
40. [Prodectin treatment of partial hearing loss as a result of atherosclerosis]. Smirnova NA; Timakov VA; Mikushkin MK Vestn Otorinolaringol; 1982; (6):53-6. PubMed ID: 7179649 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]